Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<p>A breakout late last week in the high yield spread over 10-year Treasuries can now be added to the already long list of concerns we have for the market. Continued volatility remains our expectation, and it is becoming increasingly likely that the February 2018 lows will be tested, with new YTD lows a very real possibility.  In today’s report we reiterate our U.S. investment thesis, and highlight attractive Groups within Utilities and Financials<em>.</em></p>

A breakout late last week in the high yield spread over 10-year Treasuries can now be added to the already long list of concerns we have for the market. Continued volatility remains our expectation, and it is becoming increasingly likely that the February 2018 lows will be tested, with new YTD lows a very real possibility.  In today’s report we reiterate our U.S. investment thesis, and highlight attractive Groups within Utilities and Financials.

U.S. Equity Strategy: How Much Worse Can It Get?

United States

National Health Investors, Inc. invests in income producing health care properties primarily via property ownership and providing mortgage financing. It's major assets are in the long term care industry, followed by investments in acute care hospitals, medical office buildings, assisted living facilities, retirement centers and projects for the developmentally disabled.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Natl Health Investors (NHI US)

U.S. Equity Strategy: How Much Worse Can It Get?

A breakout late last week in the high yield spread over 10-year Treasuries can now be added to the already long list of concerns we have for the...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)